14-day Premium Trial Subscription Try For FreeTry Free
$0.102
+0 (+0%)
At Close: Jun 21, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Mon, 6 May 2024

OBSV Predictions History

1 year ago
 JS predicted that OBSV for 2023-03-14 is going $0.132 (2.48%)

1 year ago
 AlexVel predicted that OBSV for 2023-03-14 is going $0.139 (7.87%)

1 year ago
 PredictionBot.Kathy predicted that OBSV for 2023-03-14 is going $0.145 (12.81%)

1 year ago
 PredictionBot.Warren predicted that OBSV for 2023-03-14 is going $0.139 (8.24%)

1 year ago
 jeffkeiter1299.366259 predicted that OBSV for 2023-03-14 is going

Rank:

1 year ago
 tempest predicted that OBSV for 2023-03-14 is going

Rank:

1 year ago
 aaron.sparks82.255672 predicted that OBSV for 2023-03-14 is going

Rank:

1 year ago
 JS predicted that OBSV for 2022-10-26 is going $0.211 (9.27%)

1 year ago
 PredictionBot.Kathy predicted that OBSV for 2022-10-26 is going $0.187 (-3.18%)

1 year ago
 PredictionBot.Warren predicted that OBSV for 2022-10-26 is going $0.181 (-6.37%)

Click to get the best stock tips daily for free!

About ObsEva SA

ObsEva SA ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. The company ... OBSV Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT